Donna L. Dehn

NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger

David Siegel, Daniel L. Gustafson, Donna L. Dehn et al. · Molecular Pharmacology · 2004 · 444 citations

Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems

Adil Anwar, Donna L. Dehn, David Siegel et al. · Journal of Biological Chemistry · 2003 · 135 citations · Full text

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration

Takashi Miyatake, Barbara Tringler, Wenhui Liu et al. · Gynecologic Oncology · 2007 · 114 citations

Tumor Biology, Endometrioid Adenocarcinomas, Tumoral Pathology +9

Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90

Russell R. A. Kitson, Chuan‐Hsin Chang, Rui Xiong et al. · Nature Chemistry · 2013 · 83 citations · Full text

Biochemistry, Natural Sciences, Molecular Biology +6

Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones 1 2 1In accordance with the policy of the University of Colorado Health Sciences Center, D.R., R.H.J.H., and J.B. declare a patent interest in RH1. 2Abbreviations: MMC, mitomycin C; NQO1, NAD(P)H:quinone oxidoreductase 1 or DT-diaphorase; MeDZQ, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone; DCPIP, 2,6-dichlorophenol-indophenol; MTT, thiazolyl blue; P450R, NADPH:cytochrome P450 reductase; b5R, NADH:cytochrome b5 reductase; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; FBS, fetal bovine serum; and MEM, Eagle’s minimum essential medium.

Shannon L. Winski, Elizabeth Swann, Robert H. J. Hargreaves et al. · Biochemical Pharmacology · 2001 · 83 citations